BR9608909A - Composto composição farmacêutica processos para estimular a liberação do hormônio do crescimento da patuitária e aumentar a velocidade e extensão do crescimento dos animais para aumentar a produção de leite ou lã de animais ou para para doenças e uso do composto - Google Patents
Composto composição farmacêutica processos para estimular a liberação do hormônio do crescimento da patuitária e aumentar a velocidade e extensão do crescimento dos animais para aumentar a produção de leite ou lã de animais ou para para doenças e uso do compostoInfo
- Publication number
- BR9608909A BR9608909A BR9608909A BR9608909A BR9608909A BR 9608909 A BR9608909 A BR 9608909A BR 9608909 A BR9608909 A BR 9608909A BR 9608909 A BR9608909 A BR 9608909A BR 9608909 A BR9608909 A BR 9608909A
- Authority
- BR
- Brazil
- Prior art keywords
- animals
- compound
- increase
- growth
- patuitaria
- Prior art date
Links
- 241001465754 Metazoa Species 0.000 title 2
- 150000001875 compounds Chemical class 0.000 title 2
- 102000018997 Growth Hormone Human genes 0.000 title 1
- 108010051696 Growth Hormone Proteins 0.000 title 1
- 201000010099 disease Diseases 0.000 title 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 title 1
- 239000000122 growth hormone Substances 0.000 title 1
- 239000008267 milk Substances 0.000 title 1
- 210000004080 milk Anatomy 0.000 title 1
- 235000013336 milk Nutrition 0.000 title 1
- 239000008194 pharmaceutical composition Substances 0.000 title 1
- 210000002268 wool Anatomy 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/575—Hormones
- C07K14/60—Growth hormone-releasing factor [GH-RF], i.e. somatoliberin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/06—Drugs for disorders of the endocrine system of the anterior pituitary hormones, e.g. TSH, ACTH, FSH, LH, PRL, GH
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C237/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
- C07C237/02—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton
- C07C237/22—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton having nitrogen atoms of amino groups bound to the carbon skeleton of the acid part, further acylated
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/02—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/06—Dipeptides
- C07K5/06008—Dipeptides with the first amino acid being neutral
- C07K5/06078—Dipeptides with the first amino acid being neutral and aromatic or cycloaliphatic
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/08—Tripeptides
- C07K5/0802—Tripeptides with the first amino acid being neutral
- C07K5/0812—Tripeptides with the first amino acid being neutral and aromatic or cycloaliphatic
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/10—Tetrapeptides
- C07K5/1002—Tetrapeptides with the first amino acid being neutral
- C07K5/1005—Tetrapeptides with the first amino acid being neutral and aliphatic
- C07K5/101—Tetrapeptides with the first amino acid being neutral and aliphatic the side chain containing 2 to 4 carbon atoms, e.g. Val, Ile, Leu
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/02—Linear peptides containing at least one abnormal peptide link
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Endocrinology (AREA)
- Molecular Biology (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Diabetes (AREA)
- Gastroenterology & Hepatology (AREA)
- Zoology (AREA)
- Toxicology (AREA)
- Reproductive Health (AREA)
- Urology & Nephrology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DK71995 | 1995-06-22 | ||
| DK137195 | 1995-12-04 | ||
| PCT/DK1996/000266 WO1997000894A1 (en) | 1995-06-22 | 1996-06-19 | Compounds with growth hormone releasing properties |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BR9608909A true BR9608909A (pt) | 1999-03-02 |
Family
ID=26064522
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BR9608909A BR9608909A (pt) | 1995-06-22 | 1996-06-19 | Composto composição farmacêutica processos para estimular a liberação do hormônio do crescimento da patuitária e aumentar a velocidade e extensão do crescimento dos animais para aumentar a produção de leite ou lã de animais ou para para doenças e uso do composto |
Country Status (12)
| Country | Link |
|---|---|
| EP (1) | EP0833845A1 (cs) |
| KR (1) | KR19990028303A (cs) |
| AU (1) | AU711104B2 (cs) |
| BR (1) | BR9608909A (cs) |
| CA (1) | CA2224434A1 (cs) |
| CZ (1) | CZ287948B6 (cs) |
| HU (1) | HUP9802821A3 (cs) |
| IL (1) | IL122371A0 (cs) |
| NO (1) | NO975992L (cs) |
| PL (1) | PL186520B1 (cs) |
| TW (1) | TW458958B (cs) |
| WO (1) | WO1997000894A1 (cs) |
Families Citing this family (26)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU3938797A (en) * | 1996-08-29 | 1998-03-19 | Novo Nordisk A/S | Transdermal delivery of peptides |
| EP1005484A1 (en) | 1997-06-20 | 2000-06-07 | Novo Nordisk A/S | Compounds with growth hormone releasing properties |
| US6127341A (en) * | 1997-06-20 | 2000-10-03 | Novo Nordisk A/S | Compounds with growth hormone releasing properties |
| KR100683445B1 (ko) | 1997-08-22 | 2007-02-20 | 가켄 세야쿠 가부시키가이샤 | 신규한 아미드 유도체 |
| HUP0100777A3 (en) | 1998-01-16 | 2001-12-28 | Novo Nordisk As | Tripeptides with growth hormone releasing properties, pharmaceutical compositions comprising thereof and their use |
| US6528529B1 (en) | 1998-03-31 | 2003-03-04 | Acadia Pharmaceuticals Inc. | Compounds with activity on muscarinic receptors |
| WO1999058505A2 (en) * | 1998-05-12 | 1999-11-18 | Warner-Lambert Company | Combinations of protein farnesyltransferase and hmg coa reductase inhibitors and their use to treat cancer |
| EP1100824B1 (en) * | 1998-06-30 | 2011-03-02 | Novo Nordisk A/S | Compounds with growth hormone releasing properties |
| US6919315B1 (en) | 1998-06-30 | 2005-07-19 | Novo Nordisk A/S | Compounds with growth hormone releasing properties |
| WO2000009537A2 (en) | 1998-08-14 | 2000-02-24 | Administrators Of The Tulane Educational Fund | Compounds having growth hormone releasing activity |
| EP1930021A3 (en) | 1999-02-18 | 2008-06-18 | Kaken Pharmaceutical Co., Ltd. | Novel amide derivatives as growth hormone secretagogues |
| EP1159964B1 (en) | 2000-05-31 | 2009-10-28 | Pfizer Products Inc. | Use of growth hormone secretagogues for stimulating gastrointestinal motility |
| WO2002060859A2 (en) | 2000-12-20 | 2002-08-08 | Bristol-Myers Squibb Company | Cyclic derivatives as modulators of chemokine receptor activity |
| AU2002241724A1 (en) | 2000-12-20 | 2002-07-01 | Bristol-Myers Squibb Company | Diamines as modulators of chemokine receptor activity |
| TWI331922B (en) | 2002-08-09 | 2010-10-21 | Ipsen Pharma Sas | Growth hormone releasing peptides |
| US7476653B2 (en) | 2003-06-18 | 2009-01-13 | Tranzyme Pharma, Inc. | Macrocyclic modulators of the ghrelin receptor |
| EP2258357A3 (en) | 2005-08-26 | 2011-04-06 | Braincells, Inc. | Neurogenesis with acetylcholinesterase inhibitor |
| EP2275096A3 (en) | 2005-08-26 | 2011-07-13 | Braincells, Inc. | Neurogenesis via modulation of the muscarinic receptors |
| CU23558A1 (es) | 2006-02-28 | 2010-07-20 | Ct Ingenieria Genetica Biotech | Compuestos análogos a los secretagogos peptidicos de la hormona de crecimiento |
| WO2008130464A1 (en) | 2007-02-09 | 2008-10-30 | Tranzyme Pharma, Inc. | Macrocyclic ghrelin receptor modulators and methods of using the same |
| US8466151B2 (en) | 2007-12-26 | 2013-06-18 | Critical Outcome Technologies, Inc. | Compounds and method for treatment of cancer |
| EP2318406B1 (en) | 2008-07-17 | 2016-01-27 | Critical Outcome Technologies, Inc. | Thiosemicarbazone inhibitor compounds and cancer treatment methods |
| CA2999435A1 (en) | 2010-04-01 | 2011-10-06 | Critical Outcome Technologies Inc. | Compounds and method for treatment of hiv |
| WO2013190520A2 (en) | 2012-06-22 | 2013-12-27 | The General Hospital Corporation | Gh-releasing agents in the treatment of vascular stenosis and associated conditions |
| US9119832B2 (en) | 2014-02-05 | 2015-09-01 | The Regents Of The University Of California | Methods of treating mild brain injury |
| US20170121385A1 (en) | 2015-10-28 | 2017-05-04 | Oxeia Biopharmaceuticals, Inc. | Methods of treating neurodegenerative conditions |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5663146A (en) * | 1991-08-22 | 1997-09-02 | Administrators Of The Tulane Educational Fund | Polypeptide analogues having growth hormone releasing activity |
| SG55069A1 (en) * | 1993-12-23 | 1998-12-21 | Novo Nordisk As | Compounds with growth hormone releasing properties |
| US5798337A (en) * | 1994-11-16 | 1998-08-25 | Genentech, Inc. | Low molecular weight peptidomimetic growth hormone secretagogues |
-
1996
- 1996-06-19 IL IL12237196A patent/IL122371A0/xx not_active IP Right Cessation
- 1996-06-19 HU HU9802821A patent/HUP9802821A3/hu unknown
- 1996-06-19 KR KR1019970709617A patent/KR19990028303A/ko not_active Ceased
- 1996-06-19 CZ CZ19974081A patent/CZ287948B6/cs not_active IP Right Cessation
- 1996-06-19 AU AU61882/96A patent/AU711104B2/en not_active Ceased
- 1996-06-19 BR BR9608909A patent/BR9608909A/pt not_active Application Discontinuation
- 1996-06-19 WO PCT/DK1996/000266 patent/WO1997000894A1/en not_active Application Discontinuation
- 1996-06-19 PL PL96324200A patent/PL186520B1/pl unknown
- 1996-06-19 EP EP96920742A patent/EP0833845A1/en not_active Withdrawn
- 1996-06-19 CA CA002224434A patent/CA2224434A1/en not_active Abandoned
- 1996-06-28 TW TW085107813A patent/TW458958B/zh not_active IP Right Cessation
-
1997
- 1997-12-19 NO NO975992A patent/NO975992L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| EP0833845A1 (en) | 1998-04-08 |
| JP4173541B2 (ja) | 2008-10-29 |
| NO975992L (no) | 1998-02-20 |
| AU711104B2 (en) | 1999-10-07 |
| TW458958B (en) | 2001-10-11 |
| KR19990028303A (ko) | 1999-04-15 |
| JPH11507928A (ja) | 1999-07-13 |
| AU6188296A (en) | 1997-01-22 |
| CZ287948B6 (cs) | 2001-03-14 |
| WO1997000894A1 (en) | 1997-01-09 |
| HUP9802821A3 (en) | 2000-03-28 |
| MX9710377A (es) | 1998-03-29 |
| CA2224434A1 (en) | 1997-01-09 |
| PL186520B1 (pl) | 2004-01-30 |
| IL122371A0 (en) | 1998-06-15 |
| NO975992D0 (no) | 1997-12-19 |
| PL324200A1 (en) | 1998-05-11 |
| CZ408197A3 (cs) | 1998-05-13 |
| HUP9802821A2 (hu) | 1999-03-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BR9608909A (pt) | Composto composição farmacêutica processos para estimular a liberação do hormônio do crescimento da patuitária e aumentar a velocidade e extensão do crescimento dos animais para aumentar a produção de leite ou lã de animais ou para para doenças e uso do composto | |
| BR9608956A (pt) | Composto composição farmacéutica e processos para aliviar a dor e para preparar um composto | |
| PT912194E (pt) | Formula de vacina polinucleotidica particularmente contra doenca respiratoria dos bovinos | |
| FI904092A7 (fi) | Lääkevalmisteita ankarien kiputilojen käsittelyyn ja menetelmä niiden valmistamiseksi | |
| ATE178204T1 (de) | Intravaginale vorrichtung zur verabreichung von 17beta-oestradiol vorläufer | |
| BR9608908A (pt) | Composto composição farmacêutica processos para aliviar dor e para preparar um composto | |
| DE3876756D1 (de) | Vorrichtung zur gesteuerten freigabe und verabreichung von wirkstoffen an tierisches gewebe. | |
| BR9609670A (pt) | Compostos processos para a preparação dos mesmos uso dos mesmos e processos de controlar pestes fúngicidas e pestes animais | |
| DE68916430D1 (de) | Arzneimittelzubereitung zur behandlung von mastitis bei tier und mensch. | |
| BR9605907A (pt) | Formulaçao de liberaçao prolongada de um hormônio de crescimento animal e processo para sua preparaçao | |
| ITMI951538A0 (it) | Procedimento ed impianto per la disidratazione di foraggio particolarmente per la disidratazione dell'erba medica | |
| PT801561E (pt) | Composicao e metodos para a entrega transdermica de drogas labeis a acido | |
| FR2748394B1 (fr) | Applicateur de medicaments pour animaux | |
| BR9603012A (pt) | Composição de resina produto moldado coleira brinco e medalha para animais processo para controlar a exsudação do composto ativo e uso do produto moldado | |
| FI972949A7 (fi) | Lääkemuoto kollagenaasin vapauttamiseksi haavoihin ja sen valmistusmen etelmiä | |
| ATE316379T1 (de) | Oxyhuminsäure und ihre verwendung zur behandlung von verschiedenenen störungen | |
| FI891069A7 (fi) | Suun kautta annettava järjestelmä vaikuttavan aineen säädettyä vapautumista varten | |
| BR9709930A (pt) | Composto composição farmacêutica uso de um composto e processos para tratamento de um indivíduo humano ou animal e para preparação de um composto | |
| BR9612362A (pt) | Compostos produto adequado para o controle de pragas animais ou de oragas fúgidas processos para o controle de pragas fúngidas e animais e para a preparação dos compostos utilização dos compostos e produtos intermediários | |
| BR9607101A (pt) | Composto formulação farmacéutica e processos para tratar tumores de animais ou de seres humanos e para produzir um composto | |
| FR2745978B1 (fr) | Produit de traitement par voie orale pour animaux | |
| AU1581795A (en) | Lure for facilitating the administration of drugs to certain animals, particularly dogs | |
| BR9608780A (pt) | Composto processos para a preparaç o de compostos para se controlar pragas fúngicas para se controlar pragas animais composiç o adequada para se controlar pragas animais ou fúngicas e uso dos compostos | |
| BR9200318A (pt) | Derivados de 3-aril-pirrolidin-2,4-diona biciclicos-substituidos,processo para a sua preparacao,composicoes praguicidas,processo para o combate de pragas animais,aplicacao dos ditos derivados,processo para a preparacao de praguicidas,processo para o combate de ervas daninhas e processo para a preparacao de composicoes herbicidas | |
| FR2809586B1 (fr) | Engin automoteur notamment pour operations de traitement et d'entretien de cultures |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B06A | Patent application procedure suspended [chapter 6.1 patent gazette] | ||
| B11B | Dismissal acc. art. 36, par 1 of ipl - no reply within 90 days to fullfil the necessary requirements |